Evaxion A (EVAX) Enterprise Value (QoQ) (2021 - 2026)

Evaxion A (EVAX) Enterprise Value (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Evaxion A 25.44 Mn 25.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 20.63%
Dec 31, 2025 -119.77%
Sep 30, 2025 28.31%
Jun 30, 2025 17.36%
Mar 31, 2025 -199.78%
Jun 30, 2024 -68,035.71%
Mar 31, 2024 99.79%
Dec 31, 2023 -114.32%
Sep 30, 2023 63.40%
Jun 30, 2023 30.49%
Mar 31, 2023 22.33%
Dec 31, 2022 26.15%
Sep 30, 2022 29.30%
Jun 30, 2022 19.60%
Mar 31, 2022 2.35%
Dec 31, 2021 -169.31%
Sep 30, 2021 36.46%
Jun 30, 2021 30.26%
Mar 31, 2021 -362.03%